Gelonghui, May 9, 丨 Tiger Pharmaceuticals (03347.HK) announced that in order to further enhance interaction with investors, Hangzhou Tiger Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the “Company”) will participate in the “2024 Zhejiang Listed Companies Investor Group Reception Day” jointly organized by the Zhejiang Securities Regulatory Bureau, the Zhejiang Listed Companies Association and Shenzhen Panorama Network Co., Ltd. The relevant matters are now announced as follows:
The event will be held remotely via the Internet. Investors can log on to the “Panorama Roadshow” website (or follow the WeChat account: Panorama Finance, or download the Panorama Roadshow app to participate in this interactive exchange. The event will be held from 15:00 to 17:00 on May 14, 2024 (Tuesday). At that time, company executives will communicate and exchange with investors online on issues of concern to investors such as the company's 2023 performance, corporate governance, development strategy, business conditions, financing plans, equity incentives and sustainable development. Investors are welcome to participate actively!